6.
Szeto S, Narimatsu M, Lu M, He X, Sidiqi A, Tolosa M
. YAP/TAZ Are Mechanoregulators of TGF--Smad Signaling and Renal Fibrogenesis. J Am Soc Nephrol. 2016; 27(10):3117-3128.
PMC: 5042658.
DOI: 10.1681/ASN.2015050499.
View
7.
Chen P, Duan Y, Lu X, Chen L, Zhang W, Wang H
. RB1CC1 functions as a tumor-suppressing gene in renal cell carcinoma via suppression of PYK2 activity and disruption of TAZ-mediated PDL1 transcription activation. Cancer Immunol Immunother. 2021; 70(11):3261-3275.
PMC: 10992581.
DOI: 10.1007/s00262-021-02913-8.
View
8.
Zanconato F, Battilana G, Cordenonsi M, Piccolo S
. YAP/TAZ as therapeutic targets in cancer. Curr Opin Pharmacol. 2016; 29:26-33.
PMC: 6175256.
DOI: 10.1016/j.coph.2016.05.002.
View
9.
Shuch B, Bratslavsky G, Linehan W, Srinivasan R
. Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies. Oncologist. 2012; 17(1):46-54.
PMC: 3267822.
DOI: 10.1634/theoncologist.2011-0227.
View
10.
Cao J, Zhao X, Wang D, Chen K, Sheng X, Li W
. YAP is overexpressed in clear cell renal cell carcinoma and its knockdown reduces cell proliferation and induces cell cycle arrest and apoptosis. Oncol Rep. 2014; 32(4):1594-600.
DOI: 10.3892/or.2014.3349.
View
11.
Zheng Y, Pan D
. The Hippo Signaling Pathway in Development and Disease. Dev Cell. 2019; 50(3):264-282.
PMC: 6748048.
DOI: 10.1016/j.devcel.2019.06.003.
View
12.
Godlewski J, Kiezun J, Krazinski B, Kozielec Z, Wierzbicki P, Kmiec Z
. The Immunoexpression of YAP1 and LATS1 Proteins in Clear Cell Renal Cell Carcinoma: Impact on Patients' Survival. Biomed Res Int. 2018; 2018:2653623.
PMC: 5903336.
DOI: 10.1155/2018/2653623.
View
13.
Mehra R, Vats P, Cieslik M, Cao X, Su F, Shukla S
. Biallelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney. Cancer Discov. 2016; 6(11):1258-1266.
PMC: 5096979.
DOI: 10.1158/2159-8290.CD-16-0267.
View
14.
Hamaratoglu F, Willecke M, Kango-Singh M, Nolo R, Hyun E, Tao C
. The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis. Nat Cell Biol. 2005; 8(1):27-36.
DOI: 10.1038/ncb1339.
View
15.
Moroishi T, Park H, Qin B, Chen Q, Meng Z, Plouffe S
. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Genes Dev. 2015; 29(12):1271-84.
PMC: 4495398.
DOI: 10.1101/gad.262816.115.
View
16.
Genevet A, Tapon N
. The Hippo pathway and apico-basal cell polarity. Biochem J. 2011; 436(2):213-24.
DOI: 10.1042/BJ20110217.
View
17.
Harvey K, Tapon N
. The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network. Nat Rev Cancer. 2007; 7(3):182-91.
DOI: 10.1038/nrc2070.
View
18.
Schutte U, Bisht S, Heukamp L, Kebschull M, Florin A, Haarmann J
. Hippo signaling mediates proliferation, invasiveness, and metastatic potential of clear cell renal cell carcinoma. Transl Oncol. 2014; 7(2):309-21.
PMC: 4101344.
DOI: 10.1016/j.tranon.2014.02.005.
View
19.
Nyimanu D, Behm C, Choudhury S, Yu A
. The role of claudin-2 in kidney function and dysfunction. Biochem Soc Trans. 2023; 51(4):1437-1445.
DOI: 10.1042/BST20220639.
View
20.
Lv M, Li S, Luo C, Zhang X, Shen Y, Sui Y
. Angiomotin promotes renal epithelial and carcinoma cell proliferation by retaining the nuclear YAP. Oncotarget. 2016; 7(11):12393-403.
PMC: 4914293.
DOI: 10.18632/oncotarget.7161.
View